216 related articles for article (PubMed ID: 32849308)
1. MicroRNA-1281 as a Novel Circulating Biomarker in Patients With Diabetic Retinopathy.
Greco M; Chiefari E; Accattato F; Corigliano DM; Arcidiacono B; Mirabelli M; Liguori R; Brunetti FS; Pullano SA; Scorcia V; Fiorillo AS; Foti DP; Brunetti A
Front Endocrinol (Lausanne); 2020; 11():528. PubMed ID: 32849308
[No Abstract] [Full Text] [Related]
2. Circulating miR-3197 and miR-2116-5p as novel biomarkers for diabetic retinopathy.
Ji H; Yi Q; Chen L; Wong L; Liu Y; Xu G; Zhao J; Huang T; Li B; Yang Y; Li W; Han L; Duan S
Clin Chim Acta; 2020 Feb; 501():147-153. PubMed ID: 31678272
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of miR-29b and miR-200b in type 2 diabetic retinopathy.
Dantas da Costa E Silva ME; Polina ER; Crispim D; Sbruzzi RC; Lavinsky D; Mallmann F; Martinelli NC; Canani LH; Dos Santos KG
J Cell Mol Med; 2019 Feb; 23(2):1280-1287. PubMed ID: 30467971
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of circulating miR-320a and target gene prediction in patients with diabetic retinopathy.
Prado MSG; de Jesus ML; de Goes TC; Mendonça LSO; Kaneto CM
BMC Res Notes; 2020 Mar; 13(1):155. PubMed ID: 32178730
[TBL] [Abstract][Full Text] [Related]
5. RNA sequencing identified specific circulating miRNA biomarkers for early detection of diabetes retinopathy.
Liang Z; Gao KP; Wang YX; Liu ZC; Tian L; Yang XZ; Ding JY; Wu WT; Yang WH; Li YL; Zhang ZB; Zhai RH
Am J Physiol Endocrinol Metab; 2018 Sep; 315(3):E374-E385. PubMed ID: 29812988
[TBL] [Abstract][Full Text] [Related]
6. Plasma microRNA signature associated with retinopathy in patients with type 2 diabetes.
Santovito D; Toto L; De Nardis V; Marcantonio P; D'Aloisio R; Mastropasqua A; De Cesare D; Bucci M; Paganelli C; Natarelli L; Weber C; Consoli A; Mastropasqua R; Cipollone F
Sci Rep; 2021 Feb; 11(1):4136. PubMed ID: 33602976
[TBL] [Abstract][Full Text] [Related]
7. Identification of miR-328-3p as an endogenous reference gene for the normalization of miRNA expression data from patients with Diabetic Retinopathy.
Prado MSG; de Goes TC; de Jesus ML; Mendonça LSO; Nascimento JS; Kaneto CM
Sci Rep; 2019 Dec; 9(1):19677. PubMed ID: 31873160
[TBL] [Abstract][Full Text] [Related]
8. Serum circulating microRNA profiling for identification of potential type 2 diabetes and obesity biomarkers.
Pescador N; Pérez-Barba M; Ibarra JM; Corbatón A; Martínez-Larrad MT; Serrano-Ríos M
PLoS One; 2013; 8(10):e77251. PubMed ID: 24204780
[TBL] [Abstract][Full Text] [Related]
9. Upregulated VEGF and Robo4 correlate with the reduction of miR-15a in the development of diabetic retinopathy.
Gong Q; Li F; Xie J; Su G
Endocrine; 2019 Jul; 65(1):35-45. PubMed ID: 30980286
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of plasma microRNA-29c-3p expression may be a new risk factor for diabetic retinopathy.
Torus B; Korkmaz H; Ozturk KH; Şirin FB; Argun M; Şevik S; Tök L
Minerva Endocrinol (Torino); 2023 Mar; 48(1):42-50. PubMed ID: 33213115
[TBL] [Abstract][Full Text] [Related]
11. Circulating MicroRNAs as Biomarker for Vessel-Associated Retinal Diseases.
Dähmcke M; Busch M; Pfeil JM; Brauckmann T; Schulz D; Omran W; Morawiec-Kisiel E; Wähler F; Paul S; Tayar A; Bründer MC; Grundel B; Stahl A
Ophthalmologica; 2023; 246(3-4):227-237. PubMed ID: 37721532
[TBL] [Abstract][Full Text] [Related]
12. Serum miRNA biomarkers serve as a fingerprint for proliferative diabetic retinopathy.
Qing S; Yuan S; Yun C; Hui H; Mao P; Wen F; Ding Y; Liu Q
Cell Physiol Biochem; 2014; 34(5):1733-40. PubMed ID: 25427542
[TBL] [Abstract][Full Text] [Related]
13. Serum microRNA-211 as a biomarker for diabetic retinopathy via modulating Sirtuin 1.
Liu HN; Cao NJ; Li X; Qian W; Chen XL
Biochem Biophys Res Commun; 2018 Nov; 505(4):1236-1243. PubMed ID: 30333091
[TBL] [Abstract][Full Text] [Related]
14. Effects of miRNA-200b on the development of diabetic retinopathy by targeting
Li EH; Huang QZ; Li GC; Xiang ZY; Zhang X
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28122882
[TBL] [Abstract][Full Text] [Related]
15. Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy.
Zou HL; Wang Y; Gang Q; Zhang Y; Sun Y
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1159-1166. PubMed ID: 28382439
[TBL] [Abstract][Full Text] [Related]
16. Molecular and functional characterization of circulating extracellular vesicles from diabetic patients with and without retinopathy and healthy subjects.
Mazzeo A; Beltramo E; Lopatina T; Gai C; Trento M; Porta M
Exp Eye Res; 2018 Nov; 176():69-77. PubMed ID: 30008390
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic role of serum miR-20b, miR-17-3p, HOTAIR, and MALAT1 in diabetic retinopathy.
Shaker OG; Abdelaleem OO; Mahmoud RH; Abdelghaffar NK; Ahmed TI; Said OM; Zaki OM
IUBMB Life; 2019 Mar; 71(3):310-320. PubMed ID: 30468285
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy.
McArthur K; Feng B; Wu Y; Chen S; Chakrabarti S
Diabetes; 2011 Apr; 60(4):1314-23. PubMed ID: 21357793
[TBL] [Abstract][Full Text] [Related]
19. microRNA Expression Profiling Based on Microarray Approach in Human Diabetic Retinopathy: A Systematic Review and Meta-Analysis.
Zhou H; Peng C; Huang DS; Liu L; Guan P
DNA Cell Biol; 2020 Mar; 39(3):441-450. PubMed ID: 32101049
[TBL] [Abstract][Full Text] [Related]
20. Altered microRNA expression profiles in retinas with diabetic retinopathy.
Wu JH; Gao Y; Ren AJ; Zhao SH; Zhong M; Peng YJ; Shen W; Jing M; Liu L
Ophthalmic Res; 2012; 47(4):195-201. PubMed ID: 22156553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
